ChemicalsMid capRs 10,103 crRs 62.3 cr traded a day
Close on 10 September 2026
1,270.80
+0.67%
52-week range67% of the way up
747.601,523.80
Market cap
10,103 cr
P/E (TTM)
143.5×
industry 36×
EPS (TTM)
8.86
Revenue YoY
+317.0%
Q1 FY27
Profit YoY
+251.3%
Net margin
3.9%
-0.7pt vs a year ago
Growth trend
+51.9pt
vs last quarter’s YoY
1 month
+21.6%
Below 52w high
19.9%
RSI (14)
63
Daily swing
3.5%
average true range
Volume
0.7×
vs 20-day average
Traded
Rs 62 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Top of the universe
+34.3%
One-year return
Below the median
-16.0%
Return on capital employed
Bottom of the universe
3.2%
Debt to equity
Bottom of the universe
0.61×
Profitable quarters, last four
of the last four reported
3 of 4
Cash conversion
cash from operations against reported profit
489%
Revenue growth, year on year
latest reported quarter
+317.0%
Below the 52-week high
from the highest close of the year
-16.6%
1 week
+1.72%
1 month
+21.64%
3 months
+41.50%
6 months
+55.74%
1 year
−16.04%
The read
written from the numbers on this page
The evidence leans constructive6 supporting, 2 against, 0 worth knowing
Supporting
trading 34% above its 200-day average
matches profit that turns into cash, which has beaten the market by +2.73 points over 20 sessions across 9,184 past signals
5 of the scans it matches have a positive measured record
3 independent kinds of evidence agree today, which is uncommon
revenue grew 317% year on year in the quarter ending 30 June 2026
net margin has widened from 0.1% to 3.9% across four quarters
Against
down 16% over twelve months
priced at 143× earnings against an industry median of 36× — 298% above its peers
Worth knowing
nothing the data supports either way
What would change this read: a close below 947, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working5
Revenue rose 279.6% year on year, from Rs 696 cr to Rs 2,642 cr.
+279.6%Rs 696 crRs 2,642 cr
Net profit rose 245.8% year on year, from Rs 30 cr to Rs 103 cr.
+245.8%Rs 30 crRs 103 cr
Operating cash flow was Rs 344 cr against Rs 70 cr profit, which is 489% of it.
Rs 344 crRs 70 cr489%
Trading 34.3% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+34.3%
Turned up over three months while the year is still negative.
+41.5% 3M-16.0% 1Y
Needs watching3
Profit grew slower than revenue, +245.8% against +279.6%.
+245.8%+279.6%
Pigments contributes 99% of segment revenue, making it the dominant business segment.
Pigments99%
Down 16.0% over the past year.
-16.0%
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 5 of these 5 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
7 of 47 matched on 10 Sep
SUDARSCHEM matches 7 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
segments and revenue mix, as the company reports them
SUDARSCHEM reports 2 business segments. The largest is Pigments at 99% of revenue in the quarter ending 30 June 2026. On these numbers this is effectively a single-segment business, so the group result and that segment’s result move together.
SegmentRevenueSharevs a year ago
Pigments2,604 cr98.6%—
Others38 cr1.4%—
Segment names are the company’s own, taken verbatim from the reportable-segment disclosure in its quarterly XBRL filing. Nothing on this page describes the business in words we wrote.
Quality of the business
balance sheet as at 31 March 2026
Return on equity
2.0%
trailing profit over shareholders’ funds
Return on capital
3.2%
pre-tax profit over equity plus borrowings
Debt to equity
0.61×
2,119 cr borrowed against 3,450 cr of equity
Net debt
1,186 cr
borrowings less cash
Cash conversion
489%
operating cash flow as a share of profit
Receivable days
75
how long customers take to pay
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
500 sessions since 26 September 2024
55×
median 68×
102×
now 143×
SUDARSCHEM trades at 143× trailing earnings, above its median of 68× over this window — 112% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Management filings were typically +0.06pt vs the market over the next 5 sessions (n=2,634) · Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · Analyst call filings were typically +0.11pt vs the market over the next 5 sessions (n=4,339)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 317% against the same quarter a year earlier
profit rose 251% year on year
net margin widened from 3.0% to 3.9%
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
2,642
144
103
12.30
3.9%
Q4 FY26
31 Mar · consolidated
2,790
162
82
10.00
3.0%
Q3 FY26
31 Dec · consolidated
2,103
-130
-116
—
-5.5%
Q3 FY25
31 Dec · consolidated
666
5
1
0.10
0.1%
Q2 FY25
30 Sep · consolidated
696
43
30
4.30
4.3%
Q1 FY25
30 Jun · consolidated
634
41
29
4.30
4.6%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+14.8%
Versus 200-day average+34.3%
Below 52-week high-16.6%
Above 52-week low+70.0%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)63.5
Higher closes in last 53 of 5
Six-month return+55.74%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)3.53%
Volume versus 20-day0.7x
Median daily turnoverRs 62.3 cr
Peers
Chemicals · 44 classified companies
SUDARSCHEM trades at 143.5× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — more expensive than them, by 298%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.